about
Current and future alternative therapies for beta-thalassemia majorPreclinical evaluation of efficacy and safety of an improved lentiviral vector for the treatment of β-thalassemia and sickle cell disease.Transplantation of Macaca cynomolgus iPS-derived hematopoietic cells in NSG immunodeficient mice.Ex Vivo Selection of Transduced Hematopoietic Stem Cells for Gene Therapy of β-Hemoglobinopathies.
P50
description
researcher ORCID ID = 0000-0002-6941-889X
@en
wetenschapper
@nl
name
Edouard de Dreuzy
@ast
Edouard de Dreuzy
@en
Edouard de Dreuzy
@es
Edouard de Dreuzy
@nl
type
label
Edouard de Dreuzy
@ast
Edouard de Dreuzy
@en
Edouard de Dreuzy
@es
Edouard de Dreuzy
@nl
prefLabel
Edouard de Dreuzy
@ast
Edouard de Dreuzy
@en
Edouard de Dreuzy
@es
Edouard de Dreuzy
@nl
P106
P1153
56582242900
P31
P496
0000-0002-6941-889X